Adhera Therapeutics, Inc. (ATRX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 10, 2026, 9:30 AM EST
Adhera Therapeutics Market Cap
Adhera Therapeutics has a market cap or net worth of $1.16 thousand as of July 14, 2026. Its market cap has decreased by -99.70% in one year.
Market Cap
1.16K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 16, 2016, Adhera Therapeutics's market cap has decreased from 2.98M to 1.16K, a decrease of -99.96%. That is a compound annual growth rate of -55.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.16K | - |
| Dec 31, 2025 | 1.16K | -99.56% |
| Dec 29, 2023 | 261.60K | -89.91% |
| Dec 30, 2022 | 2.59M | 121.55% |
| Dec 31, 2021 | 1.17M | 153.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suvanza Pharma, LLC | 2.24K |
| Evelo Biosciences | 1.90K |
| Alzex Neuropharma | 1.81K |
| Affimed | 1.64K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| TetraLogic Pharmaceuticals | 973.00 |
| RegeneRx Biopharmaceuticals | 905.00 |